Cargando...
Engineered AXL(−ECD)-Fc variants that abolish the AXL/Gas6 interaction suppress tumor cell migration
AXL receptor tyrosine kinase ligand (AXL), a tyrosine kinase receptor that is commonly overexpressed in numerous types of cancer, significantly promotes drug resistance and metastasis in tumor cells. Inhibition of the AXL/growth arrest-specific 6 (Gas6) signaling pathway is emerging as a potential a...
Guardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507473/ https://ncbi.nlm.nih.gov/pubmed/31186805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10255 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|